Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes

著录项

• 来源
  《The Journal of investigative dermatology.》 |2017年第5期|共1页
• 作者

  Siprashvili Z.; Nguyen N.; Gorell E.; Loutit K.; Dutt-Singkh Y.; Nazaroff J.; Khuu P.; Furukawa L.; Lorenz H.; Leung T.; Keene D.; Rieger K.; Khavari P. A.; Lane A.; Tang J. Y.; Marinkovich M.;

  展开▼
• 作者单位

  Stanford Univ Sch Med Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Sch Med Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  UPEN Philadelphia PA USA;

  Shriners Hosp Children Portland OR 97201 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Sch Med Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Stanford CA 94305 USA;

  Stanford Univ Sch Med Stanford CA 94305 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 皮肤病学与性病学;
• 关键词